231 related articles for article (PubMed ID: 12515810)
21. Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN.
Buckler JL; Walsh PT; Porrett PM; Choi Y; Turka LA
J Immunol; 2006 Oct; 177(7):4262-6. PubMed ID: 16982858
[TBL] [Abstract][Full Text] [Related]
22. Functional similarity and differences between selection-independent CD4-CD8- alphabeta T cells and positively selected CD8 T cells expressing the same TCR and the induction of anergy in CD4-CD8- alphabeta T cells in antigen-expressing mice.
Caveno J; Zhang Y; Motyka B; Teh SJ; Teh HS
J Immunol; 1999 Aug; 163(3):1222-9. PubMed ID: 10415017
[TBL] [Abstract][Full Text] [Related]
23. Costimulation requirements for antiviral CD8+ T cells differ for acute and persistent phases of polyoma virus infection.
Kemball CC; Lee ED; Szomolanyi-Tsuda E; Pearson TC; Larsen CP; Lukacher AE
J Immunol; 2006 Feb; 176(3):1814-24. PubMed ID: 16424212
[TBL] [Abstract][Full Text] [Related]
24. CD28 and CD27 costimulation of CD8+ T cells: a story of survival.
Dolfi DV; Katsikis PD
Adv Exp Med Biol; 2007; 590():149-70. PubMed ID: 17191384
[TBL] [Abstract][Full Text] [Related]
25. Artificial antigen-presenting cells plus IL-15 and IL-21 efficiently induce melanoma-specific cytotoxic CD8+ CD28+ T lymphocyte responses.
Yu X; He J; Mongkhoune S; Peng Y; Xie Y; Su J; Zhou SF; Xie XX; Luo GR; Fang Y; Li X; Li X; Zhou N; Zhao YX; Lu XL
Asian Pac J Trop Med; 2013 Jun; 6(6):467-72. PubMed ID: 23711708
[TBL] [Abstract][Full Text] [Related]
26. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
[TBL] [Abstract][Full Text] [Related]
27. Direct CD28 costimulation is required for CD8+ T cell-mediated resistance to an acute viral disease in a natural host.
Fang M; Sigal LJ
J Immunol; 2006 Dec; 177(11):8027-36. PubMed ID: 17114476
[TBL] [Abstract][Full Text] [Related]
28. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
[TBL] [Abstract][Full Text] [Related]
29. Memory CD8+ T cells require CD28 costimulation.
Borowski AB; Boesteanu AC; Mueller YM; Carafides C; Topham DJ; Altman JD; Jennings SR; Katsikis PD
J Immunol; 2007 Nov; 179(10):6494-503. PubMed ID: 17982038
[TBL] [Abstract][Full Text] [Related]
30. Duration of TCR stimulation determines costimulatory requirement of T cells.
Kündig TM; Shahinian A; Kawai K; Mittrücker HW; Sebzda E; Bachmann MF; Mak TW; Ohashi PS
Immunity; 1996 Jul; 5(1):41-52. PubMed ID: 8758893
[TBL] [Abstract][Full Text] [Related]
31. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
32. Influence of antigen dose and costimulation on the primary response of CD8+ T cells in vitro.
Cai Z; Sprent J
J Exp Med; 1996 May; 183(5):2247-57. PubMed ID: 8642334
[TBL] [Abstract][Full Text] [Related]
33. Peripheral tolerance in CD8+ T cells.
Srinivasan M; Frauwirth KA
Cytokine; 2009 May; 46(2):147-59. PubMed ID: 19268604
[TBL] [Abstract][Full Text] [Related]
34. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.
Li Y; McGowan P; Hellström I; Hellström KE; Chen L
J Immunol; 1994 Jul; 153(1):421-8. PubMed ID: 7515929
[TBL] [Abstract][Full Text] [Related]
35. CD28 engagement inhibits CD73-mediated regulatory activity of CD8
Lai YP; Kuo LC; Lin BR; Lin HJ; Lin CY; Chen YT; Hsiao PW; Chang HT; Ko PC; Chen HC; Chang HY; Lu J; Ho HN; Wu-Hsieh BA; Kung JT; Chen SC
Commun Biol; 2021 May; 4(1):595. PubMed ID: 34011962
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones.
Posnett DN; Edinger JW; Manavalan JS; Irwin C; Marodon G
Int Immunol; 1999 Feb; 11(2):229-41. PubMed ID: 10069421
[TBL] [Abstract][Full Text] [Related]
37. Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice.
Manning TC; Rund LA; Gruber MM; Fallarino F; Gajewski TF; Kranz DM
J Immunol; 1997 Nov; 159(10):4665-75. PubMed ID: 9366389
[TBL] [Abstract][Full Text] [Related]
38. Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation.
Trimble LA; Shankar P; Patterson M; Daily JP; Lieberman J
J Virol; 2000 Aug; 74(16):7320-30. PubMed ID: 10906185
[TBL] [Abstract][Full Text] [Related]
39. MHC class Ib-restricted CD8 T cells differ in dependence on CD4 T cell help and CD28 costimulation over the course of mouse polyomavirus infection.
Hofstetter AR; Ford ML; Sullivan LC; Wilson JJ; Hadley A; Brooks AG; Lukacher AE
J Immunol; 2012 Apr; 188(7):3071-9. PubMed ID: 22393155
[TBL] [Abstract][Full Text] [Related]
40. HIV-specific cytotoxic T lymphocyte precursors exist in a CD28-CD8+ T cell subset and increase with loss of CD4 T cells.
Lewis DE; Yang L; Luo W; Wang X; Rodgers JR
AIDS; 1999 Jun; 13(9):1029-33. PubMed ID: 10397532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
